• BFH772 (VEGFR2 inhibitor): Workflow Guide

  2026-09-16

  BFH772 is a selective VEGFR2 kinase inhibitor for controlled studies of VEGFR2 signaling, endothelial responses, and tumor angiogenesis. Its water insolubility makes solvent control essential, and the product should not be treated as a broad kinase inhibitor or as evidence of a validated clinical protocol.

• 2'3'-cGAMP: Translating STING Biology into Strategy

  2026-09-16

  A translational guide to using 2'3'-cGAMP (sodium salt) as a mechanistic benchmark for STING activation, combination immunotherapy research, and evidence-driven assay design, informed by a photodynamic therapy study in breast cancer.

• How Kinase Inhibitors Tune p38α Dephosphorylation

  2026-09-15

  The reference study shows that some kinase inhibitors do more than block p38α catalytic activity: they also stabilize an activation-loop conformation that accelerates dephosphorylation by WIP1. Biochemical measurements and X-ray structures establish a dual-action mechanism with implications for designing more selective kinase inhibitors, while also defining important limits on translation beyond purified protein systems.

• FAST Nanoparticles for Nutraceutical Delivery

  2026-09-15

  The reference study evaluates Facilitated Self-Assembling Technology (FAST) as a food-grade, surfactant-free route for producing stable nanoparticles from poorly soluble nutraceuticals. Its results indicate that hybrid formulations improve colloidal behavior and simulated gastric stability while retaining cellular compatibility, although in vivo bioavailability and manufacturing-scale validation remain necessary.

• 2'3'-cGAMP: STING and Migration Assay Workflows

  2026-09-14

  Build reproducible cGAS-STING assays with water-soluble 2'3'-cGAMP (sodium salt), then extend the workflow to study the Rab18–FosB migration axis described in recent research. This paired strategy separates canonical type I interferon induction from noncanonical cell-migration phenotypes while providing practical handling and troubleshooting guidance.

• CBX2, Interferon Signaling, and Tumor Immunogenicity

  2026-09-14

  This PNAS study identifies a noncanonical CBX2–RACK1–HDAC1 corepressor complex that suppresses interferon-stimulated genes and reduces tumor immunogenicity independently of canonical polycomb repression. The findings connect CBX2 loss with tumor immune activation and improved responses to anti-PD-1 and adoptive T-cell therapies, while positioning CBX2 as a potential immunotherapy biomarker and mechanistic target.

• Triazole ALDH2 Activators for Myocardial Ischemia

  2026-09-13

  This 2025 ACS Medicinal Chemistry Letters study used molecular simulation and medicinal chemistry to develop triazole aldehyde dehydrogenase 2 activators with improved activity and water solubility. Lead compound Z17 produced strong ALDH2 activation and improved cardiac and biochemical outcomes in a mouse ischemia-reperfusion model, supporting ALDH2 as a preclinical therapeutic strategy rather than establishing clinical efficacy.

• Norovirus Co-opts NINJ1 for Selective Protein Secretion

  2026-09-12

  This study identifies NINJ1 as a host factor that murine norovirus exploits to release the viral protein NS1 through an unconventional, caspase-3-dependent pathway. Its combination of CRISPR screening, cell biology, mutational analysis, and mouse infection models shows how membrane rupture can support selective viral protein export while also releasing cellular damage signals.

• ABT-888 (Veliparib) Experimental Workflow

  2026-09-11

  ABT-888 (Veliparib) enables controlled PARP1/2 inhibition for DNA repair, chemotherapy-sensitization, and radiation-response studies. This guide focuses on formulation, combination assays, MSI and colorectal cancer models, and the limits revealed by a recent leukemia drug-resistance study.

• Resiniferatoxin (RTX): From TRPV1 to Translation

  2026-09-11

  Resiniferatoxin (RTX) is more than an ultra-potent TRPV1 agonist: it is a mechanistic tool for converting receptor activation into selective sensory-afferent silencing. This article connects RTX workflows with membrane cholesterol biology, model selection, route strategy, and translational decision-making in pain and neurogenic inflammation research.

• Ziprasidone HCl: A Context-Aware Assay Framework

  2026-09-10

  Ziprasidone HCl connects receptor pharmacology, formulation science, and emerging GOT1-directed oncology research. This guide presents a context-aware framework for separating compound mechanism from exposure, permeability, and assay artifacts.

• EZ Cap™ Firefly Luciferase mRNA: Smarter Assays

  2026-09-10

  EZ Cap™ Firefly Luciferase mRNA enables sensitive translation and delivery studies with a Cap 1 structure and optimized poly(A) tail. This article explains why luciferase signal should be interpreted as the combined result of RNA integrity, carrier release, cytosolic availability, and cell physiology.

• HyperScribe T7 Cy3 RNA Labeling Kit Guide

  2026-09-09

  The HyperScribe T7 High Yield Cy3 RNA Labeling Kit is a 25-reaction in vitro transcription system for producing randomly Cy3-modified RNA probes. Its tunable Cy3-UTP incorporation supports fluorescent probe workflows such as in situ hybridization and Northern blotting without establishing therapeutic mRNA-delivery performance.

• Quercetin Suppresses NLRP3 in LPS-Induced Depression

  2026-09-09

  A 2026 pre-proof study reports that Quercetin reduced depressive-like behavior and cognitive impairment in an LPS-induced mouse model by suppressing hippocampal NLRP3 inflammasome-associated neuroinflammation. The work connects mood-related behavior, memory performance, microglial responses, and inflammatory cytokines, providing a mechanistic basis for further preclinical evaluation rather than clinical evidence of antidepressant efficacy.

• Arachidonic Acid in Reliable Cell Assays

  2026-09-08

  This scenario-driven guide explains how Arachidonic Acid (SKU C4223) can improve the design, dosing, and interpretation of cell viability, proliferation, and cytotoxicity experiments. It connects formulation data, lipid-signaling biology, solvent controls, and vendor-selection criteria to practical laboratory decisions.

8232 records 1/549 page Next 12345 下5页 Last page